CRT is a vibrant drug discovery, technology transfer and commercialisation company which aims to advance new discoveries to beat cancer. At the present time, CRT employs some 140 people, including a large complement of scientists, business development specialists and professional support groups spanning five sites throughout the UK, with close partnerships working with associated operations in the USA and Australia. As a wholly owned subsidiary of Cancer Research UK, we have extensive experience in developing and licensing oncology related opportunities with world-class pharmaceutical and biotechnology companies.
© Cancer Research Technology 2012